301
Views
22
CrossRef citations to date
0
Altmetric
Report

Androgen receptor serine 81 mediates Pin1 interaction and activity

, , , , , , , & show all
Pages 3415-3420 | Received 13 Jun 2012, Accepted 03 Aug 2012, Published online: 16 Aug 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Giulio Poli, Miriana Di Stefano, Joan Arias Estevez, Filippo Minutolo, Carlotta Granchi, Antonio Giordano, Salvatore Parisi, Matteo Mauceri, Vincenzo Canzonieri, Marco Macchia, Isabella Caligiuri, Tiziano Tuccinardi & Flavio Rizzolio. (2022) New PIN1 inhibitors identified through a pharmacophore-driven, hierarchical consensus docking strategy. Journal of Enzyme Inhibition and Medicinal Chemistry 37:1, pages 145-150.
Read now

Articles from other publishers (21)

Gloria Saorin, Matteo Mauceri, Enrico Cavarzerani, Isabella Caligiuri, Giulia Bononi, Carlotta Granchi, Michele Bartoletti, Tiziana Perin, Tiziano Tuccinardi, Vincenzo Canzonieri, Muhammad Adeel & Flavio Rizzolio. (2023) Enhanced activity of a pluronic F127 formulated Pin1 inhibitor for ovarian cancer therapy. Journal of Drug Delivery Science and Technology 87, pages 104718.
Crossref
Jacky K. Leung, Amy H. Tien & Marianne D. Sadar. 2021. Nuclear Receptors. Nuclear Receptors 411 461 .
Woo Jin Kim, Bong Soo Kim, Hyun Jung Kim, Young Dan Cho, Hye Lim Shin, Hee In Yoon, Yun Sil Lee, Jeong-Hwa Baek, Kyung Mi Woo & Hyun-Mo Ryoo. (2020) Intratesticular Peptidyl Prolyl Isomerase 1 Protein Delivery Using Cationic Lipid-Coated Fibroin Nanoparticle Complexes Rescues Male Infertility in Mice. ACS Nano 14:10, pages 13217-13231.
Crossref
Simeng Wen, Yuanjie Niu & Haojie Huang. (2020) Posttranslational regulation of androgen dependent and independent androgen receptor activities in prostate cancer. Asian Journal of Urology 7:3, pages 203-218.
Crossref
Ji Hoon Yu, Chun Young Im & Sang-Hyun Min. (2020) Function of PIN1 in Cancer Development and Its Inhibitors as Cancer Therapeutics. Frontiers in Cell and Developmental Biology 8.
Crossref
Concetta Russo Spena, Lucia De Stefano, Giulio Poli, Carlotta Granchi, Maguie El Boustani, Fabrizio Ecca, Gabriele Grassi, Mario Grassi, Vincenzo Canzonieri, Antonio Giordano, Tiziano Tuccinardi, Isabella Caligiuri & Flavio Rizzolio. (2019) Virtual screening identifies a PIN1 inhibitor with possible antiovarian cancer effects. Journal of Cellular Physiology 234:9, pages 15708-15716.
Crossref
Alessandro Zannini, Alessandra Rustighi, Elena Campaner & Giannino Del Sal. (2019) Oncogenic Hijacking of the PIN1 Signaling Network. Frontiers in Oncology 9.
Crossref
Maguie El Boustani, Lucia De Stefano, Isabella Caligiuri, Nayla Mouawad, Carlotta Granchi, Vincenzo Canzonieri, Tiziano Tuccinardi, Antonio Giordano & Flavio Rizzolio. (2019) A Guide to PIN1 Function and Mutations Across Cancers. Frontiers in Pharmacology 9.
Crossref
Justin X. Nicoll, Andrew C. Fry & Eric M. Mosier. (2019) Sex-based differences in resting MAPK, androgen, and glucocorticoid receptor phosphorylation in human skeletal muscle. Steroids 141, pages 23-29.
Crossref
Joshua W. Russo, Xiaming Liu, Huihui Ye, Carla Calagua, Sen Chen, Olga Voznesensky, James Condulis, Fen Ma, Mary-Ellen Taplin, David J. Einstein, Steven P. Balk & Shaoyong Chen. (2018) Phosphorylation of androgen receptor serine 81 is associated with its reactivation in castration-resistant prostate cancer. Cancer Letters 438, pages 97-104.
Crossref
Concetta Russo Spena, Lucia De Stefano, Stefano Palazzolo, Barbara Salis, Carlotta Granchi, Filippo Minutolo, Tiziano Tuccinardi, Roberto Fratamico, Sara Crotti, Sara D'Aronco, Marco Agostini, Giuseppe Corona, Isabella Caligiuri, Vincenzo Canzonieri & Flavio Rizzolio. (2018) Liposomal delivery of a Pin1 inhibitor complexed with cyclodextrins as new therapy for high-grade serous ovarian cancer. Journal of Controlled Release 281, pages 1-10.
Crossref
Sang-Hyun Min, Xiao Zhen Zhou & Kun Ping Lu. (2016) The role of Pin1 in the development and treatment of cancer. Archives of Pharmacal Research 39:12, pages 1609-1620.
Crossref
Nooshin Mirkheshti, Sulgi Park, Shoulei Jiang, Jodie Cropper, Sherry L. Werner, Chung S. Song & Bandana Chatterjee. (2016) Dual targeting of androgen receptor and mTORC1 by salinomycin in prostate cancer. Oncotarget 7:38, pages 62240-62254.
Crossref
Xiao Zhen Zhou & Kun Ping Lu. (2016) The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target. Nature Reviews Cancer 16:7, pages 463-478.
Crossref
Ryuhei Kanaoka, Akifumi Kushiyama, Yasuyuki Seno, Yusuke Nakatsu, Yasuka Matsunaga, Toshiaki Fukushima, Yoshihiro Tsuchiya, Hideyuki Sakoda, Midori Fujishiro, Takeshi Yamamotoya, Hideaki Kamata, Akio Matsubara & Tomoichiro Asano. (2015) Pin1 Inhibitor Juglone Exerts Anti-Oncogenic Effects on LNCaP and DU145 Cells despite the Patterns of Gene Regulation by Pin1 Differing between These Cell Lines. PLOS ONE 10:6, pages e0127467.
Crossref
Prashant Rajbhandari, Mary Szatkowski Ozers, Natalia M. Solodin, Christopher L. Warren & Elaine T. Alarid. (2015) Peptidylprolyl Isomerase Pin1 Directly Enhances the DNA Binding Functions of Estrogen Receptor α. Journal of Biological Chemistry 290:22, pages 13749-13762.
Crossref
Nithya Krishnan, Mark A. Titus & Roopa Thapar. (2014) The Prolyl Isomerase Pin1 Regulates mRNA Levels of Genes with Short Half-Lives by Targeting Specific RNA Binding Proteins. PLoS ONE 9:1, pages e85427.
Crossref
T. M. Poolman, S. N. Farrow, L. Matthews, A. S. Loudon & D. W. Ray. (2013) Pin1 promotes GR transactivation by enhancing recruitment to target genes. Nucleic Acids Research 41:18, pages 8515-8525.
Crossref
Lindsey S. Treviño & Nancy L. Weigel. (2013) Phosphorylation: a fundamental regulator of steroid receptor action. Trends in Endocrinology & Metabolism 24:10, pages 515-524.
Crossref
Raffaele La Montagna, Isabella Caligiuri, Antonio Giordano & Flavio Rizzolio. (2013) Pin1 and Nuclear Receptors: A New Language?. Journal of Cellular Physiology 228:9, pages 1799-1801.
Crossref
Travis Van der Steen, Donald Tindall & Haojie Huang. (2013) Posttranslational Modification of the Androgen Receptor in Prostate Cancer. International Journal of Molecular Sciences 14:7, pages 14833-14859.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.